Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation.

MicroRNAs (miRNAs), recently identified noncoding small RNAs, are emerging as key regulators in homeostasis of the immune system. Therefore, aberrant expression of miRNAs may be linked to immune dysfunction, such as in chronic inflammation and autoimmunity. In this study, we investigated the potential role of miRNAs in estrogen-mediated regulation of innate immune responses, as indicated by up-regulation of lipopolysaccharide (LPS)-induced interferon-gamma (IFNgamma), inducible nitric oxide synthase (iNOS), and nitric oxide in splenic lymphocytes from estrogen-treated mice. We found that miR-146a, a negative regulator of Toll-like receptor (TLR) signaling, was decreased in freshly isolated splenic lymphocytes from estrogen-treated mice compared with placebo controls. Increasing the activity of miR-146a significantly inhibited LPS-induced IFNgamma and iNOS expression in mouse splenic lymphocytes. Further, miRNA microarray and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that estrogen selectively up-regulates/down-regulates the expression of miRNAs in mouse splenic lymphocytes. miR-223, which is markedly enhanced by estrogen, regulates LPS-induced IFNgamma, but not iNOS or nitric oxide in splenic lymphocytes. Inhibition of miR-223 activity decreased LPS-induced IFNgamma in splenic lymphocytes from estrogen-treated mice. Our data are the first to demonstrate the selective regulation of miRNA expression in immune cells by estrogen and are indicative of an important role of miRNAs in estrogen-mediated immune regulation.

[1]  A. Negassa,et al.  Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. , 2008, Journal of the National Cancer Institute.

[2]  B. Travi,et al.  Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone‐modulated nitric oxide production , 2008, Journal of leukocyte biology.

[3]  A. Pivarcsi,et al.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. , 2008, Seminars in cancer biology.

[4]  M. Shmoish,et al.  Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. , 2008, Endocrinology.

[5]  O. Kirak,et al.  Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 , 2008, Nature.

[6]  A. Scott,et al.  17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. , 2008, Journal of immunology.

[7]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[8]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[9]  Muller Fabbri,et al.  Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1 , 2007, The Journal of Immunology.

[10]  Steven P. O'Hara,et al.  A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection* , 2007, Journal of Biological Chemistry.

[11]  O. Kovalchuk,et al.  Estrogen-Induced Rat Breast Carcinogenesis is Characterized by Alterations in DNA Methylation, Histone Modifications, and Aberrant microRNA Expression , 2007, Cell cycle.

[12]  A. Mansell,et al.  The negative regulation of Toll‐like receptor and associated pathways , 2007, Immunology and cell biology.

[13]  B. Williams,et al.  Fine‐tuning of the innate immune response by microRNAs , 2007, Immunology and cell biology.

[14]  R. Dai,et al.  Despite Inhibition of Nuclear Localization of NF-κB p65, c-Rel, and RelB, 17-β Estradiol Up-Regulates NF-κB Signaling in Mouse Splenocytes: The Potential Role of Bcl-31 , 2007, The Journal of Immunology.

[15]  Chris Sander,et al.  Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. , 2007, Blood.

[16]  Rebecca A. Phillips,et al.  Estrogen selectively regulates chemokines in murine splenocytes , 2007, Journal of leukocyte biology.

[17]  Grace X. Y. Zheng,et al.  Dynamic regulation of miRNA expression in ordered stages of cellular development. , 2007, Genes & development.

[18]  S. Ansar Ahmed,et al.  IFN-gamma-inducing transcription factor, T-bet is upregulated by estrogen in murine splenocytes: role of IL-27 but not IL-12. , 2007, Molecular immunology.

[19]  John D Lambris,et al.  Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. , 2007, Molecular immunology.

[20]  D. Baltimore,et al.  MicroRNAs and immunity: tiny players in a big field. , 2007, Immunity.

[21]  Rebecca A. Phillips,et al.  17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes. , 2006, Journal of molecular endocrinology.

[22]  L. O’Neill,et al.  Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. , 2006, Biochemical pharmacology.

[23]  M. Jovanović,et al.  miRNAs and apoptosis: RNAs to die for , 2006, Oncogene.

[24]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[25]  S. Ansar Ahmed,et al.  Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma. , 2006, Endocrinology.

[26]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[27]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[28]  Chris Sander,et al.  MicroRNA profiling of the murine hematopoietic system , 2005, Genome Biology.

[29]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[30]  S. Rivest,et al.  Estradiol Is Required for a Proper Immune Response to Bacterial and Viral Pathogens in the Female Brain 1 , 2005, The Journal of Immunology.

[31]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[32]  B. Garmy-Susini,et al.  Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. , 2005, Blood.

[33]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[34]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[35]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[36]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[37]  M. Fenton,et al.  Toll-Like Receptor 4 and Toll-IL-1 Receptor Domain-Containing Adapter Protein (TIRAP)/Myeloid Differentiation Protein 88 Adapter-Like (Mal) Contribute to Maximal IL-6 Expression in Macrophages1 , 2002, The Journal of Immunology.

[38]  J. Mershon,et al.  Estrogen increases iNOS expression in the ovine coronary artery. , 2002, American journal of physiology. Heart and circulatory physiology.

[39]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[40]  A. Mantovani,et al.  Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. , 2002, Blood.

[41]  S. Ahmed,et al.  Interferon-γ levels are upregulated by 17-β-estradiol and diethylstilbestrol , 2001 .

[42]  S. Ahmed,et al.  Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. , 2001, Cytokine.

[43]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[44]  D. Verthelyi,et al.  Gender and risk of autoimmune diseases: possible role of estrogenic compounds. , 1999, Environmental health perspectives.

[45]  D J Dix,et al.  Application of DNA arrays to toxicology. , 1999, Environmental health perspectives.

[46]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Ansar Ahmed,et al.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. , 1985, The American journal of pathology.

[48]  R. Dai,et al.  Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. , 2007, Journal of immunology.

[49]  I. Marriott,et al.  Sexual dimorphism in innate immune responses to infectious organisms , 2006, Immunologic research.

[50]  S. Akira,et al.  TLR signaling. , 2006, Current topics in microbiology and immunology.

[51]  Hans C. van Houwelingen,et al.  Microarray Data Analysis , 2004 .

[52]  I. Chaudry,et al.  Gender dimorphism in immune responses following trauma and hemorrhage , 2002, Immunologic research.

[53]  S. Ansar Ahmed,et al.  Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. , 2001, Journal of reproductive immunology.

[54]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[55]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .